Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward.

[1]  Andrew S. Levey,et al.  Notice , 2012, Kidney International Supplements.

[2]  G. Schernthaner,et al.  Notice , 2012, Kidney International Supplements.

[3]  A. Khwaja.  KDIGO Clinical Practice Guidelines for Acute Kidney Injury , 2012, Nephron Clinical Practice.

[4]  J. Adamson,et al.  Notice , 2012, Kidney International Supplements.

[5]  Norbert Lameire,et al.  Notice , 2012, Kidney International Supplements.

[6]  Keng T Woo,et al.  KDIGO clinical practice guidelines for bisphosphonate treatment in chronic kidney disease. , 2011, Kidney International.

[7]  Neil R. Powe,et al.  Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. , 2007, Kidney international.

[8]  G. Guyatt,et al.  Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.

[9]  Keith C. Norris,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  T. Connor,et al.  Renal handling of calcium and phosphate during mineralocorticoid "escape" in man. , 1972, Kidney international.

[11]  H E de Wardener,et al.  Effect of urinary extracts from salt-loaded man on urinary sodium excretion by the rat. , 1972, Kidney international.

[12]  B. Kasiske,et al.  KDIGO Clinical Practice Guideline for Glomerulonephritis , 2012 .

[13]  W. G. Walker,et al.  Plasma aldosterone regulation in anephric man. , 1973, Kidney international.